# Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers

> **NCT03742791** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical R&D Inc.** · enrollment: 59 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TS-134
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03742791
- **Lead sponsor:** Taisho Pharmaceutical R&D Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-28
- **Primary completion:** 2016-12-12
- **Final completion:** 2016-12-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742791, "Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03742791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*